Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-95.54%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-95.54%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-49.24%
40%
—
—
Never
—
5 Years
Score—
Net Growth-49.24%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Forte Biosciences Inc fundamental performance
Across Forte Biosciences Inc's full reported history, from 2017 to 2025, revenue declined from $ 41K to $ 0.00 and net income went from -$ 38M to -$ 69M. Revenue increased in 13% of the years measured; net income in 38%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 76.78 | — |
1 Year2025-08-12 | $ 10.76 | 7x |
5 Years2021-08-12 | $ 660.75 | -88.38% |
All Time2017-04-13 | $ 4.67K | -98.36% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-04-13 |
|---|---|---|---|---|
| Price | $ 76.78 | $ 10.76 | $ 660.75 | $ 4.67K |
| Return | — | 7x | -88.38% | -98.36% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 69M | $ 76M |
| 2024 | $ 0.00 | -$ 35M | $ 58M |
| 2023 | $ 0.00 | -$ 31M | $ 37M |
| 2022 | $ 0.00 | -$ 13M | $ 41M |
| 2021 | $ 0.00 | -$ 21M | $ 42M |
| 2020 | $ 0.00 | -$ 46M | $ 58M |
| 2019 | $ 36K | -$ 4M | $ 6M |
| 2018 | $ 18M | -$ 48M | $ 96M |
| IPO2017 | $ 41K | -$ 38M | $ 88M |
Explore beyond FBRX
You're looking at Forte Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
